Preoperative GLP-1 Receptor Agonist Use and Risk of Postoperative Respiratory Complications

Anjali A Dixit; Brian T Bateman; Mary T Hawn; Michelle C Odden; Eric C Sun

doi:10.1001/jama.2024.5003

Preoperative GLP-1 Receptor Agonist Use and Risk of Postoperative Respiratory Complications

JAMA. 2024 May 21;331(19):1672-1673. doi: 10.1001/jama.2024.5003.

Authors

Anjali A Dixit¹, Brian T Bateman¹, Mary T Hawn², Michelle C Odden³, Eric C Sun¹

Affiliations

¹ Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.
² Department of Surgery, Stanford University School of Medicine, Stanford, California.
³ Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California.

No abstract available

Plain language summary

This cohort study evaluates the risk of postoperative respiratory complications among patients with diabetes undergoing surgery who had vs those who had not a prescription fill for glucagon-like peptide 1 receptor agonists.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Female
Glucagon-Like Peptide-1 Receptor Agonists* / administration & dosage
Glucagon-Like Peptide-1 Receptor Agonists* / adverse effects
Glucagon-Like Peptide-1 Receptor Agonists* / therapeutic use
Humans
Hypoglycemic Agents* / adverse effects
Hypoglycemic Agents* / therapeutic use
Male
Middle Aged
Postoperative Complications / chemically induced
Respiratory Tract Diseases* / chemically induced
Respiratory Tract Diseases* / etiology
Risk
Withholding Treatment

Substances

Hypoglycemic Agents
Glucagon-Like Peptide-1 Receptor Agonists

Plain language summary

Publication types

MeSH terms

Substances

Grants and funding